Dipòsit Digital de Documents de la UAB 416 registres trobats  1 - 10següentfinal  anar al registre: La cerca s'ha fet en 0.01 segons. 
1.
How to Handle Concomitant Asymptomatic Prosthetic Joints during an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter Analysis / Wouthuyzen-Bakker, M. (Department of Medical Microbiology and Infection Prevention. University of Groningen. University Medical Center Groningen) ; Sebillotte, M. (Department of Infectious Diseases and Intensive Care Medicine. Rennes University Hospital) ; Arvieux, C. (Great West Reference Centers for Complex Bone and Joint Infections (CRIOGO)) ; Fernandez-Sampedro, M. (Service of Infectious Diseases. Hospital Universitario Marqués de Valdecilla. University of Cantabria. Instituto de Investigación Sanitaria Valdecilla (IDIVAL)) ; Senneville, E. (Department of Infectious Diseases Lille. University Hospital Gustave Dron Hospital) ; Barbero, J.M. (Department of Internal Medicine. Hospital Universitario Principe de Asturias) ; Lora-Tamayo, J. (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ; Aboltins, C. (University of Melbourne. Northern Clinical School) ; Trebse, R. (Service for Bone Infections. Valdoltra Orthopaedic Hospital. Faculty of Medicine. University of Ljublijana) ; Salles, M.J. (Santa Casa de São Paulo School of Medical Sciences and Musculoskeletal Infection Group. Federal University of São Paulo) ; Kramer, T.S. (Evangelisches Waldkrankenhaus Spandau) ; Ferrari, M. (Istituto di Ricovero e Cura A Carattere Scientifico (IRCCS) Humanitas Research Hospital) ; Garcia-Cañete, J. (Department of Internal Medicine-Emergency. Instituto de Investigación Sanitaria (IIS)-Fundación Jiménez Díaz. Universidad Autónoma de Madrid (UAM)) ; Benito, Natividad (Institut d'Investigació Biomèdica Sant Pau) ; Diaz-Brito, V. (Infectious Diseases Unit. Parc Sanitari Sant Joan de Deu. Sant Boi) ; Del Toro, M.D. (Unidad Clínica de Enfermedades Infecciosa y Microbiología. Universidad de Sevilla. Instituto de Biomedicina de Sevilla (IBIS)) ; Scarborough, M. (Bone Infection Unit. Nuffield Orthopaedic Centre. Oxford University Hospitals National Health Service (NHS) Foundation Trust) ; Soriano, Alex (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Background: Prosthetic joints are at risk of becoming infected during an episode of bacteremia, especially during Staphylocococcus aureus bacteremia. However, it is unclear how often asymptomatic periprosthetic joint infection (PJI) occurs, and whether additional diagnostics should be considered. [...]
2021 - 10.1093/cid/ciaa1222
Clinical Infectious Diseases, Vol. 73 Núm. 11 (january 2021) , p. E3820-E3824  
2.
One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction / Chiva-Blanch, Gemma (Faculty of Medicine. University of Oslo) ; Bratseth, V. (Faculty of Medicine. University of Oslo) ; Laake, K. (Faculty of Medicine. University of Oslo) ; Arnesen, H. (Faculty of Medicine. University of Oslo) ; Solheim, S. (Faculty of Medicine. University of Oslo) ; Schmidt, E.B. (Department of Cardiology. Aalborg University Hospital) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Seljeflot, I. (Faculty of Medicine. University of Oslo)
Background & aims: Circulating microvesicles (cMV) are both effectors and biomarkers of cardiovascular disease (CVD), and the effects of omega 3 polyunsaturated fatty acids (n3 PUFA) in MV shedding are not yet well known. [...]
2021 - 10.1016/j.clnu.2021.10.007
Clinical Nutrition, Vol. 40 Núm. 12 (december 2021) , p. 5674-5677  
3.
Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients / Bermudez-Lopez, M. (Vascular and Renal Translational Research Group. Spanish Research Network for Renal Diseases (REDINREN Del ISCIII). IRBLleida) ; Perpiñan, H. (Conselleria de Sanitat Universal i Salut Pública. Generalitat Valenciana) ; Amigó, Núria (Biosfer Teslab SL) ; Castro, E. (Vascular and Renal Translational Research Group. Spanish Research Network for Renal Diseases (REDINREN Del ISCIII). IRBLleida) ; Alonso, N. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Fernandez, E. (Vascular and Renal Translational Research Group. Spanish Research Network for Renal Diseases (REDINREN Del ISCIII). IRBLleida) ; Valdivielso, José Manuel (Vascular and Renal Translational Research Group. Spanish Research Network for Renal Diseases (REDINREN Del ISCIII). IRBLleida)
Background: Chronic kidney disease (CKD) patients have a high burden of atheromatous cardiovascular disease (ASCVD) not fully explained by traditional lipid parameters. Lipoprotein composition and subclass particle number information could improve ASCVD risk assessment. [...]
2021 - 10.1093/ckj/sfab113
Clinical Kidney Journal, Vol. 14 Núm. 12 (january 2021) , p. 2591-2599  
4.
6 p, 1.6 MB Novel PLEKHG5 mutations in a patient with childhood-onset lower motor neuron disease / Gonzalez-Quereda, Lidia (Institut d'Investigació Biomèdica Sant Pau) ; Pagola, I. (Instituto de Investigación Sanitaria de Navarra) ; Fuentes Prior, Pablo (Institut d'Investigació Biomèdica Sant Pau) ; Bernal, Sara (Institut d'Investigació Biomèdica Sant Pau) ; Rodriguez, María José (Institut d'Investigació Biomèdica Sant Pau) ; Torné, L. (Neurology Department. Complejo Universitario de Navarra. IdisNa) ; Salgado Garrido, J. (Instituto de Investigación Sanitaria de Navarra) ; Gallano, Pia (Institut d'Investigació Biomèdica Sant Pau) ; Jericó, I. (Instituto de Investigación Sanitaria de Navarra)
The PLEKHG5 gene encodes a protein that activates the nuclear factor kappa B (NFκB) signaling pathway. Mutations in this gene have been associated with distal spinal muscular atrophy IV and intermediate axonal neuropathy C, both with an autosomal recessive mode of inheritance. [...]
2021 - 10.1002/acn3.51265
Annals of Clinical and Translational Neurology, Vol. 8 Núm. 1 (january 2021) , p. 294-299  
5.
10 p, 1.3 MB Analysis of the effectiveness of second oral glucose-lowering therapy in routine clinical practice from the mediterranean area : A retrospective cohort study / Vlacho, Bogdan (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Mundet-Tudurí, X. (Universitat Autònoma de Barcelona. Departament de Medicina) ; Mata-Cases, M. (CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM). Instituto de Salud Carlos III (ISCIII)) ; Vallès-Callol, J.A. (Institut d'Investigació en Atenció Primària Jordi Gol) ; Real, J. (CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM). Instituto de Salud Carlos III (ISCIII)) ; Farré, M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Cos Claramunt, Francesc Xavier (Institut d'Investigació en Atenció Primària Jordi Gol) ; Khunti, K. (Diabetes Research Centre. University of Leicester) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Franch-Nadal, J. (CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM). Instituto de Salud Carlos III (ISCIII)) ; Universitat Autònoma de Barcelona
Aim: To compare the changes in HbA1c, the effect on body weight or both combined after the addition of a DPP-4i, SGLT-2i, or sulfonylureas (SU) to metformin in real-world condition. Methods: We used a primary care SIDIAP database. [...]
2021 - 10.1016/j.diabres.2020.108616
Diabetes Research and Clinical Practice, Vol. 171 (january 2021) , p. 108616  
6.
7 p, 586.4 KB Real-world management of hyperphosphataemia with sucroferric oxyhydroxide : The VELREAL multicentre study / Navarro-González, J.F. (ERA-EDTA Working Group on CKD-MBD) ; Arenas, M.D. (Servicio de Nefrología. Hospital Del Mar) ; Henríquez-Palop, F. (Centro de Diálisis Avericum Norte) ; Lloret, María Jesús (Institut d'Investigació Biomèdica Sant Pau) ; Molina, P. (Servicio de Nefrología. Hospital Universitario Dr. Peset) ; Ríos Moreno, F. (Centro Diálisis San Luciano) ; MacIa-Lagier, M.A. (Servicio de Nefrología. Hospital General de la Palma) ; Espinel, L. (Servicio de Nefrología. Hospital Universitario de Getafe) ; Sánchez, E. (Servicio de Nefrología. Hospital Universitario de Cabueñes) ; Lago, M. (Servicio de Nefrología. Complejo Hospitalario Universitario Insular) ; Crespo, A. (Servicio de Nefrología. Hospital Marina Baixa) ; Bover, Jordi (Institut d'Investigació Biomèdica Sant Pau)
Background. The efficacy and safety of sucroferric oxyhydroxide (SO) have been reported in clinical trials. However, real-life data are scarce. This study presents data on the use, efficacy and safety of SO in real clinical practice. [...]
2021 - 10.1093/ckj/sfaa226
Clinical Kidney Journal, Vol. 14 Núm. 2 (january 2021) , p. 681-687  
7.
8 p, 396.6 KB Correlation between plateletworks® and pfa-100® for measuring platelet function before urgent surgery in patients with chronic antiplatelet therapy / Anaya, Rafael (Anesthesiology Service, Hospital de la Santa Creu i Sant Pau) ; Rodriguez, Mireia (Institut d'Investigació Biomèdica Sant Pau) ; Gil, José María (Institut d'Investigació Biomèdica Sant Pau) ; Vilalta, Noelia (Institut d'Investigació Biomèdica Sant Pau) ; Merchan-Galvis, Ángela (Institut d'Investigació Biomèdica Sant Pau) ; Moral, Victoria (Institut d'Investigació Biomèdica Sant Pau) ; Mateo, José (Institut d'Investigació Biomèdica Sant Pau) ; Martinez-Zapata, María José (Institut d'Investigació Biomèdica Sant Pau)
Hemostasis is crucial for reducing bleeding during surgical procedures. The points-of-care based on the platelet function test could be useful to minimize the complications related to chronic antiplatelet therapy during surgery. [...]
2021 - 10.3390/jcm10020255
Journal of clinical medicine, Vol. 10 Núm. 2 (february 2021) , p. 1-8  
8.
13 p, 254.3 KB First-line maintenance treatment in metastatic colorectal cancer (mCRC) : Quality and clinical benefit overview / Martín-Richard, Marta (Institut d'Investigació Biomèdica Sant Pau) ; Tobeña, M. (Quironsalud Hospital)
Different strategies of maintenance therapy (sequential CT, intermittent CT, intermittent CT and MAbs, or de-escalation MAbs monotherapy) after first-line treatment are undertaken. Many randomized clinical trials (RCT), which evaluated these approaches, suffer from incorrect design, heterogenous primary endpoints, inadequate size, and other methodology flaws. [...]
2021 - 10.3390/jcm10030470
Journal of clinical medicine, Vol. 10 Núm. 3 (january 2021) , p. 1-13  
9.
11 p, 3.8 MB Percutaneous mitral valve repair : Outcome improvement with operator experience and a second-generation device / Freixa, X. (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ; Estévez-Loureiro, R. (Hospital Universitario de León) ; Carrasco-Chinchilla, F. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Millán, X. (Institut d'Investigació Biomèdica Sant Pau) ; Amat-Santos, I. (Hospital Clínico Universitario (Valladolid)) ; Regueiro, A. (Hematology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain) ; Nombela-Franco, L. (Hospital Clínico San Carlos (Madrid)) ; Pascual, I. (Hospital Universitario Central de Asturias) ; Cid, B. (Complejo Hospitalario Universitario de Santiago de Compostela) ; López-Mínguez, J.R. (Hospital Universitario Infanta Cristina) ; Hernández-Antolín, R.A. (Hospital Universitario Ramón y Cajal (Madrid)) ; Cruz-González, Ignacio (Hospital Clínico Universitario (Salamanca)) ; Andraka, L. (Hospital Civil de Basurto) ; Goicolea, J. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Ruíz-Quevedo, V. (Complejo Hospitalario de Navarra) ; Díez, J.L. (Hospital Universitari i Politècnic La Fe de València) ; Berenguer, A. (Hospital General Universitario de Valencia) ; Baz, J.A. (Complejo Hospitalario Universidad de Vigo) ; Pan, M. (Hospital Reina Sofía de Córdoba) ; Benito-González, T. (Hospital Universitario de León) ; Alonso Briales, J.H. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Li, Chi Hion (Institut d'Investigació Biomèdica Sant Pau) ; Sanchis, L. (Hematology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain) ; Serrador, A. (Hospital Clínico Universitario (Valladolid)) ; Jiménez-Quevedo, P. (Hospital Clínico San Carlos (Madrid)) ; Avanzas, P. (Hospital Universitario Central de Asturias) ; Salido, L. (Hospital Universitario Ramón y Cajal (Madrid)) ; Fernández-Vázquez, F. (Hospital Universitario de León) ; Hernández-García, J.M. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Arzamendi, Dabit (Institut d'Investigació Biomèdica Sant Pau)
Background and aim: Recent randomized data comparing percutaneous mitral valve repair (PMVR) versus optimal medical treatment in patients with functional MR (FMR) seemed to highlight the importance of the learning curve not only for procedural outcomes but also for patient selection. [...]
2021 - 10.3390/jcm10040734
Journal of clinical medicine, Vol. 10 Núm. 4 (february 2021) , p. 1-10  
10.
16 p, 758.5 KB Pd-(L)1 inhibitors as monotherapy for the first-line treatment of non-small-cell lung cancer patients with high pd-l1 expression : A network meta-analysis / Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ; Cobo, M. (Medical Oncology. Hospital Regional Universitario de Málaga) ; Isla, Dolores (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ; Marquez-Medina, D. (Medical Oncology. University Hospital Miguel Servet) ; Rodriguez-Abreu, D. (Medical Oncology. Hospital Universitario Insular de Gran Canaria) ; Casal-Rubio, J. (Medical Oncology Service. Hospital Álvaro Cunqueiro) ; Bueno, T.M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bernabé-Caro, R. (Medical Oncology Department. Hospital Virgen del Rocío) ; Parente, D.P. (Medical Affairs Department. Roche Farma S.A) ; Ruiz-Gracia, P. (Medical Affairs Department. Roche Farma S.A) ; Arroyo, M.M. (Medical Affairs Department. Roche Farma S.A) ; Paz-Ares, L. (Hospital Universitario 12 de Octubre (Madrid))
Programmed cell death-ligand 1 (PD-L1) has emerged as a potential biomarker for selec-tion of patients more likely to respond to immunotherapy and as a prognostic factor in non-small cell lung cancer (NSCLC). [...]
2021 - 10.3390/jcm10071365
Journal of clinical medicine, Vol. 10 Núm. 7 (april 2021) , p. 1365  

Dipòsit Digital de Documents de la UAB : 416 registres trobats   1 - 10següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.